Boston Sci Closes Acquisition of Medtronic’s Neuromodulation Foe

Boston Scientific has closed on its $3.7 billion acquisition of Axonics.

The Marlborough, MA-based company first announced the deal in January. Axonics develops devices to treat urinary and bowel dysfunction.